Neuropharmacology and Drug Interactions in Clinical Practice
- 1 February 1995
- Vol. 36 (s2) , S27-S33
- https://doi.org/10.1111/j.1528-1157.1995.tb05997.x
Abstract
Absorption, distribution, and clearance are key pharmacokinetic principles. These parameters can be highly variable among patients and among compounds, and are factors that must be considered in the wide variability in response to medications. Current antiepileptic drugs (AEDs) present many challenges in their administration. However, understanding and utilizing pharmacokinetic principles can assist the clinician in the appropriate optimization of AEDs.Keywords
This publication has 18 references indexed in Scilit:
- Lack of serious toxicity following gabapentin overdoseNeurology, 1994
- Derivation and Evaluation of an Equation for Prediction of Free Phenytoin Concentration in Patients Co-Medicated with Valproic AcidTherapeutic Drug Monitoring, 1989
- Effect of food on the serum concentration profile of entericcoated valproic acidNeurology, 1988
- Interference of oral phenytoin absorption by continuous nasogastric feedingsNeurology, 1982
- Pharmacokinetic Comparison of Sublingual Lorazepam with Intravenous, Intramuscular, and Oral LorazepamJournal of Pharmaceutical Sciences, 1982
- Valproic acid dosage and plasma protein binding and clearanceClinical Pharmacology & Therapeutics, 1980
- Valproic AcidTherapeutic Drug Monitoring, 1979
- Pharmacokinetics and Bioavailability of Intravenous, Intramuscular, and Oral Lorazepam in HumansJournal of Pharmaceutical Sciences, 1979
- Valproic acid in epilepsy: Clinical and pharmacological effectsAnnals of Neurology, 1978
- SERUM-PHENYTOIN LEVELS IN MANAGEMENT OF EPILEPSYThe Lancet, 1975